ProShare Advisors
PRCT icon

ProShare Advisors’s Procept Biorobotics PRCT Stock Holding History

ProShare Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,726
Closed -$306K – 1989
2025
Q4 		$306K Buy
9,726
+438
+5% +$14.5K ﹤0.01% 1446
2025
Q3 		$331K Sell
9,288
-1,841
-17% -$84.1K ﹤0.01% 1351
2025
Q2 		$641K Buy
11,129
+1,308
+13% +$74K ﹤0.01% 981
2025
Q1 		$572K Sell
9,821
-2,901
-23% -$198K ﹤0.01% 1021
2024
Q4 		$1.02M Buy
12,722
+4,459
+54% +$381K ﹤0.01% 902
2024
Q3 		$662K Buy
8,263
+2,598
+46% +$185K ﹤0.01% 972
2024
Q2 		$346K Sell
5,665
-1,585
-22% -$94.3K ﹤0.01% 1189
2024
Q1 		$358K Buy
7,250
+570
+9% +$27.1K ﹤0.01% 1302
2023
Q4 		$280K Buy
+6,680
New +$227K ﹤0.01% 1433

Other funds holding PRCT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return